Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 21 Prostatic Neoplasms 7 Thyroid Nodule 4 Neoplasms 4 Liver Neoplasms 4 Urinary Bladder Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Sarcopenia 3 Rectal Neoplasms 3 Polycystic Ovary Syndrome 3 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Mouth Neoplasms 3 Liver Cirrhosis 3 Endometrial Neoplasms 3 Brain Neoplasms 3 Uterine Cervical Neoplasms 2 Tongue Neoplasms 2 Thyroid Neoplasms 2 Postoperative Complications 2 Ovarian Cysts 2 Lung Neoplasms 2 Kidney Neoplasms 2 Hypersensitivity 2 Head and Neck Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Uveal Melanoma 1 Urologic Neoplasms 1 Urethral Neoplasms 1

Interventions

Ipilimumab 29 Nivolumab 23 pembrolizumab 14 incomplete Freund's adjuvant 10 Cyclophosphamide 10 Melphalan 9 Interleukin-2 9 CTLA-4 Antigen 8 tebentafusp 7 sargramostim 7 Temozolomide 7 MART-1 Antigen 7 Dacarbazine 7 Ranibizumab 6 montanide ISA 51 5 fludarabine phosphate 5 fludarabine 5 Sunitinib 5 Radiosurgery 5 Carboplatin 5 Blood Specimen Collection 5 Bevacizumab 5 aldesleukin 4 aflibercept 4 Surveys and Questionnaires 4 Magnetic Resonance Spectroscopy 4 Granulocyte-Macrophage Colony-Stimulating Factor 4 Biopsy 4 trametinib 3 sotrastaurin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Uveal Melanoma × Ultrasonography × Clear all

NCT06284512 2024-02-29

Uveal Melanoma - Comparative Study

Medical University of Vienna

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡